These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2994679)

  • 21. Inhibitory effects of gold sodium thiomalate on DNA polymerase alpha.
    Takeuchi F; Hanaoka F; Matsuta K; Miyamoto T
    Clin Exp Rheumatol; 1989; 7(6):595-601. PubMed ID: 2515017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular antiproliferative action exerted by auranofin.
    Simon TM; Kunishima DH; Vibert GJ; Lorber A
    J Rheumatol Suppl; 1979; 5():91-7. PubMed ID: 226702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Auranofin and sodium aurothiomalate: a comparative review. I. Physicochemical, pharmacokinetic and pharmacological properties].
    Batlle Gualda E
    Med Clin (Barc); 1985 May; 84(20):834-9. PubMed ID: 3928990
    [No Abstract]   [Full Text] [Related]  

  • 24. Metallothionein in cultured human epithelial cells and synovial rheumatoid fibroblasts after in vitro treatment with auranofin.
    Glennås A; Hunziker PE; Garvey JS; Kägi JH; Rugstad HE
    Biochem Pharmacol; 1986 Jun; 35(12):2033-40. PubMed ID: 3087367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Auranofin. Mechanism of action, pharmacokinetics and clinical use. Comparison with injectable gold salts].
    Chamouard JM; Clerc D; Bisson M; Medicis P; Massias P
    Rev Rhum Mal Osteoartic; 1985 Apr; 52(4):277-82. PubMed ID: 3923604
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of the molecular pharmacology of gold and platinum complexes.
    Crooke ST
    J Rheumatol Suppl; 1982; 8():61-70. PubMed ID: 6813493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of auranofin (SK&F 39162) on water and electrolyte flux in canine small bowel: a possible diarrheogenic mechanism.
    Fondacaro JD; Henderson LS; Hardcastle PT; Hardcastle J; Kelleher DK; Ormsbee HS
    J Rheumatol; 1986 Apr; 13(2):288-93. PubMed ID: 3014142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of gold compounds on lymphocyte transformation and neutrophil chemotaxis--a comparison between sodium aurothiomalate and auranofin].
    Negishi M; Sato H; Sekine F; Ohno I; Kobayashi K; Ohseto Y; Hamai T; Takahashi T
    Ryumachi; 1983 Jun; 23(3):163-7. PubMed ID: 6414094
    [No Abstract]   [Full Text] [Related]  

  • 29. Modulation of human immune responsiveness in vitro by auranofin.
    Salmeron G; Lipsky PE
    J Rheumatol Suppl; 1982; 8():25-31. PubMed ID: 6813487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of mammalian stress proteins by a triethylphosphine gold compound used in the therapy of rheumatoid arthritis.
    Caltabiano MM; Koestler TP; Poste G; Greig RG
    Biochem Biophys Res Commun; 1986 Aug; 138(3):1074-80. PubMed ID: 3092816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitory effects of a new oral gold compound on HeLa cells.
    Simon TM; Kunishima DH; Vibert GJ; Lorber A
    Cancer; 1979 Dec; 44(6):1965. PubMed ID: 389401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Superoxide radical production by human leukocytes exposed to immune complexes: inhibitory action of gold compounds.
    Roisman FR; Walz DT; Finkelstein AE
    Inflammation; 1983 Dec; 7(4):355-62. PubMed ID: 6317558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunopharmacology of auranofin and gold sodium thiomalate: effects on humoral immunity.
    Walz DT; DiMartino MJ; Griswold DE
    J Rheumatol Suppl; 1979; 5():74-81. PubMed ID: 114651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The efficacy of parenteral gold after auranofin failure in rheumatoid arthritis.
    Wessel J; Davis P
    J Rheumatol; 1983 Aug; 10(4):664. PubMed ID: 6413690
    [No Abstract]   [Full Text] [Related]  

  • 35. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.
    Chaffman M; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 May; 27(5):378-424. PubMed ID: 6426923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Auranofin affects early events in human polymorphonuclear neutrophil activation by receptor-mediated stimuli.
    Hafström I; Seligmann BE; Friedman MM; Gallin JI
    J Immunol; 1984 Apr; 132(4):2007-14. PubMed ID: 6321596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug information: auranofin (Ridaura). Oral administration of gold for polyarthritis].
    MMW Munch Med Wochenschr; 1983 Mar; 125(12):88-9. PubMed ID: 6406850
    [No Abstract]   [Full Text] [Related]  

  • 38. Screening trial with the coordinated gold compound auranofin using mouse lymphocyte leukemia P388.
    Simon TM; Kunishima DH; Vibert GJ; Lorber A
    Cancer Res; 1981 Jan; 41(1):94-7. PubMed ID: 6778607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of auranofin dose regimen change upon cell-associated gold in rheumatoid arthritic patients.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1981; 8(5):829-32. PubMed ID: 6796684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of eucaryotic deoxyribonucleic acid polymerases alpha and gamma in the replication of cellular and viral deoxyribonucleic acid.
    Krokan H; Schaffer P; DePamphilis ML
    Biochemistry; 1979 Oct; 18(20):4431-43. PubMed ID: 226127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.